DARATUMUMAB AND HYALURONIDASE-FIHJ (HUMAN RECOMBINANT)

DARATUMUMAB AND HYALURONIDASE-FIHJ (HUMAN RECOMBINANT) was reported 0 times

DARATUMUMAB AND HYALURONIDASE-FIHJ (HUMAN RECOMBINANT) is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency